Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Synthetic peptide, fibrinogen derivative; glyco...
Potent and selective inhibitor
Endogenous peptide involved in vascular contrac...
V600E B-Raf inhibitor.
Benzimidazole; microtubule polymerization inhib...
p110α PI3K inhibitor.
Pyrimidine analog; inhibits thymidylate synthas...
Nav1.7 and Nav1.8 N1+ channel blocker.
Immunodominant peptide epitope occurring in mul...
Cephalomannine derivative found in Taxus; poten...
TTK/CLK2 inhibitor.
Alkylamine; histamine H1 antagonist, SERT and N...
Iron chelator.
Tetracycline; protein translation inhibitor.
Neuropeptide found in insects.
Endogenous cardiomodulatory peptide; NPR-B agon...
Mycotoxin produced by Alternaria; photosynthesi...
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Isoflavone, phytoestrogen found in soy; ER agon...
Endogenous calcitonin-family peptide, involved ...